Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.
about
Anti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULESProgress in the development of effective vaccines to prevent selected gram-positive bacterial infections.A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.Oral vaccination: where we are?StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunityProspects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.Intranasal vaccines for protection against respiratory and systemic bacterial infections.Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.Moving forward: a mucosal vaccine against group A streptococcus.Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii.In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.
P2860
Q27666345-FDDD1B5C-AD65-4398-AC49-EBC741FBA552Q34112608-6932409A-3F26-432E-BA04-109531B67B65Q34260712-DC565CE1-AD46-42E9-BEDB-3F928E1B8628Q34660422-EC167026-02BC-43DA-9B26-3EFC2BA0B7A6Q34674395-FEB1DC78-C33E-4F80-962E-CA6F4FB9E2ECQ35913475-854566D4-5D21-4702-AD86-9985BE4CD406Q36257688-88B8F669-989C-40DA-88CC-702AE061817CQ36837156-116DD4E5-ABFB-4C57-844D-16E15C721B3EQ36974497-D0F94EE3-17DE-404E-B280-391C9A981068Q37503248-D4FD7DE5-3D70-4457-8BDE-66318E1BF637Q39179768-BDD300D4-4DDA-439B-8E17-333A0E610EE3Q40234321-56A5A2AE-B61C-4AEE-B841-0C66544276E4Q42581247-8ED0B423-96C9-4CB3-A93E-32A09F23E419
P2860
Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Clinical and microbiological r ...... group A streptococcus vaccine.
@en
type
label
Clinical and microbiological r ...... group A streptococcus vaccine.
@en
prefLabel
Clinical and microbiological r ...... group A streptococcus vaccine.
@en
P2093
P2860
P1476
Clinical and microbiological r ...... group A streptococcus vaccine.
@en
P2093
Christine A Franke
Dennis E Hruby
Kevin F Jones
Sofie Livio
Steven S Wasserman
Vincent A Fischetti
P2860
P304
P356
10.1128/IAI.73.4.2360-2366.2005
P407
P577
2005-04-01T00:00:00Z